Attached files
| file | filename |
|---|---|
| EX-23.1 - CONSENT - Mosaic ImmunoEngineering Inc. | patriot_10q-ex2301.htm |
| EX-31.1 - CERTIFICATION - Mosaic ImmunoEngineering Inc. | patriot_10q-ex3101.htm |
| EX-23.2 - CONSENT - Mosaic ImmunoEngineering Inc. | patriot_10q-ex2302.htm |
| EX-31.2 - CERTIFICATION - Mosaic ImmunoEngineering Inc. | patriot_10q-ex3102.htm |
| 10-Q - PATRIOT SCIENTIFIC CORPORATION FORM 10-Q - Mosaic ImmunoEngineering Inc. | patriot_10q-083109.htm |
Exhibit
32.1
CERTIFICATION
FURNISHED PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the quarterly report of Patriot Scientific Corporation (the
“Company”) on Form 10-Q for the period ended August 31, 2009, as filed with
the Securities and Exchange Commission and to which this Certification is an
exhibit (the “Report”), the undersigned officer of the Company does hereby
certify, pursuant to Rule 13a–14(b) or Rule 15d–14(b) of the Securities and
Exchange Act of 1934, as amended, and Section 1350 of Chapter 63 of Title 18 of
the United States Code, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to his knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
Date:
October 9, 2009
|
/s/
Clifford L. Flowers
Clifford
L. Flowers
Interim Chief Executive
Officer
and
Chief Financial Officer
|